Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

H3K27ac nucleosomes facilitate HMGN localization at regulatory sites to modulate chromatin binding of transcription factors.

Autor: Zhang S; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Maryland, USA., Postnikov Y; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Maryland, USA., Lobanov A; CCR Collaborative Bioinformatics Resource, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Maryland, MD, USA., Furusawa T; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Maryland, USA., Deng T; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Maryland, USA.; Cell Translation Laboratory, NCATS, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD, 20850, USA., Bustin M; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, Maryland, USA. bustinm@mail.nih.gov.

Publikováno v: Communications biology [Commun Biol] 2022 Feb 23; Vol. 5 (1), pp. 159. Date of Electronic Publication: 2022 Feb 23.

Chromatin accessibility promotes hematopoietic and leukemia stem cell activity.

Autor: Cabal-Hierro L; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., van Galen P; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Prado MA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Higby KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Togami K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Mowery CT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Paulo JA; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Xie Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Furusawa T; Laboratory of Metabolism, National Cancer Institute, Bethesda, MD, USA., Bustin M; Laboratory of Metabolism, National Cancer Institute, Bethesda, MD, USA., Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA., Sykes DB; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA, USA., Gygi SP; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Finley D; Department of Cell Biology, Harvard Medical School, Boston, MA, USA., Bernstein BE; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. andrew_lane@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. andrew_lane@dfci.harvard.edu.

Publikováno v: Nature communications [Nat Commun] 2020 Mar 16; Vol. 11 (1), pp. 1406. Date of Electronic Publication: 2020 Mar 16.

HMGN2 represses gene transcription via interaction with transcription factors Lef-1 and Pitx2 during amelogenesis.

Autor: Eliason S; Department of Anatomy and Cell Biology and the Craniofacial Anomalies Research Center, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA., Su D; Department of Anatomy and Cell Biology and the Craniofacial Anomalies Research Center, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA., Pinho F; Janssen R&D, LLC, San Diego, California, USA., Sun Z; Washington University St Louis, St Louis, Missouri, USA., Zhang Z; Institute for Biosciences and Technology, Houston, Texas, USA., Li X; Texas Heart Institute, Houston, Texas, USA., Sweat M; Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Venugopalan SR; Department of Orthodontics, The University of Iowa, Iowa City, Iowa, USA., He B; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bustin M; Protein Section, Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Amendt BA; Department of Anatomy and Cell Biology and the Craniofacial Anomalies Research Center, Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA; Department of Orthodontics, The University of Iowa, Iowa City, Iowa, USA. Electronic address: brad-amendt@uiowa.edu.

Publikováno v: The Journal of biological chemistry [J Biol Chem] 2022 Sep; Vol. 298 (9), pp. 102295. Date of Electronic Publication: 2022 Jul 21.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.